OSLO, Norway--(BUSINESS WIRE)--Nordic Nanovector AS strengthens its management team by appointing two highly experienced executives to key leadership roles. The executives will play pivotal roles as the Company continues to explore different avenues to leverage its proprietary targeting technology for optimal long-term value creation. Effective November 3rd 2014, Nordic Nanovector announces the appointment of 2 new executive officers: Cristina Oliva, MD as Chief Medical Officer and Marco Renoldi, MD as Chief Business Officer, both reporting to Mr. Luigi Costa, Chief Executive Officer.
Help employers find you! Check out all the jobs and post your resume.
